结果治疗组患者总胆红素（TBIL）、直接胆红素（DBIL）、间接胆红素（IBIL）均比对照组明显降低。
Results The group's patient total bilirubin(TBIL), direct bilirubin(DBIL), the indirect bilirubin(IBIL)obviously reduces than the contrast group.
患者耐受性指标中，强化组无显著变化，对照组则出现血葡萄糖和总胆红素升高。
For tolerance parameters, blood glucose and total bilirubin increased obviously in control group with no change in LALG group.
方法采用酶法对68例冠心病患者的血清甘油三酯（TG）、胆固（CHOL）高密度胆固醇（HDL-C）水平，钒酸盐氧化法测定血清总胆红素（TBIL）。
Methods serum TG, CHOL, HDL-C were detected in 68 patients with CHD by using enzymatic method and TBIL by vanadate oxidation method.
结果83例患者血清总胆红素水平较术前降低30%以上，引流术的有效率为94.3%（83/88）。
Results Serum total bilirubin decreased more than 30% in 83 patients and the efficacy rate of PTBD procedure was 94.3%(83/88).
结果83例患者血清总胆红素水平较术前降低30%以上，引流术的有效率为94.3%（83/88）。
Results Serum total bilirubin decreased more than 30% in 83 patients and the efficacy rate of PTBD procedure was 94.3%(83/88).
应用推荐